Patients with rheumatic diseases like rheumatoid arthritis, systemic lupus erythematosus [22], and systemic sclerosis, which are characterized by a chronic inflammatory vessel activation, show reduced levels of GBP-1 in their peripheral blood [44]. Here, GBP1 is linked to rheumatic disorder.